Worldwide Protein Detection & Quantification Industry to 2027 - Featuring General Electric, PerkinElmer and Shimadzu Among Others

DUBLIN, June 20, 2022 /PRNewswire/ -- The "Protein Detection & Quantification Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global protein detection & quantification market reached a value of US$ 2.25 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 4.05 Billion by 2027 exhibiting a CAGR of 9.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Protein detection and quantification refer to methods that are generally adopted by scientific experts in order to determine the total protein content and its characteristics. It helps to develop a comparison between two distinctive protein samples, measure enzyme kinetics, and verify the success of the lysis step. Some of the commonly used techniques for protein detection and quantification include enzyme-linked immunosorbent assay (ELISA), mass spectrometry, western blot analysis and nanoparticles and nanopore-based methods. As a result, it is extensively utilized across academic institutions, research organizations, and biotechnology and pharmaceutical companies for research studies and clinical diagnosis.

Protein Detection & Quantification Market Trends:

The global market is primarily driven by significant growth in the pharmaceutical industry. Along with this, various technological advancements in biotechnology are acting as major growth-inducing factors. For instance, the widespread adoption of infrared spectroscopy and immunoassay techniques that assist experts in attaining accurate results is expected to impact the market growth favorably.

Moreover, increasing investments by private and public agencies to conduct extensive research and development (R&D) in the field of proteomics is one of the key factors driving the growth of the market across the globe. Furthermore, the rising prevalence of chronic illnesses that have propelled the need to diagnose diseases at a molecular level in order to develop therapeutic treatments is providing a boost to the market growth on the global level. Other factors, including the increasing investments to upgrade the existing healthcare infrastructure and continuous improvements in the genomics industry, are also projected to drive the market growth.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, General Electric Company, Inanovate Inc., Merck KGaA, PerkinElmer Inc., RayBiotech Life Inc., Shimadzu Corporation and Thermo Fisher Scientific Inc.

Key Questions Answered in this Report:

• How has the global protein detection & quantification market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global protein detection & quantification market?
• What are the key regional markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the technology?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global protein detection & quantification market and who are the key players?
• What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Protein Detection & Quantification Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product
6.1 Kits and Reagents/Consumables
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Services
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Technology
7.1 Colorimetric Assays
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Immunological Methods
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Chromatography
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Mass Spectrometry
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Spectroscopy Instruments
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast

8 Market Breakup by Application
8.1 Drug Discovery and Development
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinical Diagnosis
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by End User
9.1 Academic Research Institutes
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Biotechnology and Pharmaceutical Companies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Contract Research Organization
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Agilent Technologies Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Bio-Rad Laboratories Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Danaher Corporation
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 General Electric Company
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Inanovate Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Merck KGaA
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 PerkinElmer Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 RayBiotech Life Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Shimadzu Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Thermo Fisher Scientific Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/z27obn

Media Contact:

Research and Markets 
Laura Wood, Senior Manager 
[email protected] 

For E.S.T Office Hours Call +1-917-300-0470 
For U.S./CAN Toll Free Call +1-800-526-8630 
For GMT Office Hours Call +353-1-416-8900 

U.S. Fax: 646-607-1907 
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets